CD4 and HIV infectious disease: Projected cost savings were due to the greater number of pediatric HIV infections averted with POC; savings occurred within 36 months after delivery in regions with high access to laboratory CD4 testing and within 6 months in regions with lower access to laboratory CD4 testing [51], and persisted throughout the lifetimes of mother-infant pairs.